Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Low-Dose and Long-Term Olaparib Treatment Sensitizes MDA-MB-231 and SUM1315 Triple-Negative Breast Cancers Spheroids to Fractioned Radiotherapy.

Dubois C, Martin F, Hassel C, Magnier F, Daumar P, Aubel C, Guerder S, Mounetou E, Penault-Lorca F, Bamdad M.

J Clin Med. 2019 Dec 26;9(1). pii: E64. doi: 10.3390/jcm9010064.

2.

Thymus-specific serine protease, a protease that shapes the CD4 T cell repertoire.

Guerder S, Hassel C, Carrier A.

Immunogenetics. 2019 Mar;71(3):223-232. doi: 10.1007/s00251-018-1078-y. Epub 2018 Sep 17. Review.

PMID:
30225612
3.

Thymic-Specific Serine Protease Limits Central Tolerance and Exacerbates Experimental Autoimmune Encephalomyelitis.

Serre L, Girard M, Ramadan A, Menut P, Rouquié N, Lucca LE, Mahiddine K, Leobon B, Mars LT, Guerder S.

J Immunol. 2017 Dec 1;199(11):3748-3756. doi: 10.4049/jimmunol.1700667. Epub 2017 Oct 23.

4.

The site of tumor development determines immunogenicity via temporal mobilization of antigen-laden dendritic cells in draining lymph nodes.

Joncker NT, Bettini S, Boulet D, Guiraud M, Guerder S.

Eur J Immunol. 2016 Mar;46(3):609-18. doi: 10.1002/eji.201545797. Epub 2015 Dec 22.

5.

The T Cell Repertoire-Diversifying Enzyme TSSP Contributes to Thymic Selection of Diabetogenic CD4 T Cell Specificities Reactive to ChgA and IAPP Autoantigens.

Viret C, Mahiddine K, Baker RL, Haskins K, Guerder S.

J Immunol. 2015 Sep 1;195(5):1964-73. doi: 10.4049/jimmunol.1401683. Epub 2015 Jul 24.

6.

Central tolerance spares the private high-avidity CD4(+) T-cell repertoire specific for an islet antigen in NOD mice.

Serre L, Fazilleau N, Guerder S.

Eur J Immunol. 2015 Jul;45(7):1946-56. doi: 10.1002/eji.201445290. Epub 2015 May 12.

7.

Dendritic cells in tolerance and autoimmune diabetes.

Guerder S, Joncker N, Mahiddine K, Serre L.

Curr Opin Immunol. 2013 Dec;25(6):670-5. doi: 10.1016/j.coi.2013.10.004. Epub 2013 Oct 26. Review.

PMID:
24168964
8.

Retroviral transduction of lineage antigen-negative ((Lin−) cells: a valuable alternative for the generation of T cell receptor (TCR) retrogenic mice.

Viret C, Cresson C, Broccardo C, Guerder S.

J Immunol Methods. 2012 Oct 31;384(1-2):103-10. doi: 10.1016/j.jim.2012.07.014. Epub 2012 Jul 31.

PMID:
22867746
9.

Differential processing of self-antigens by subsets of thymic stromal cells.

Guerder S, Viret C, Luche H, Ardouin L, Malissen B.

Curr Opin Immunol. 2012 Feb;24(1):99-104. doi: 10.1016/j.coi.2012.01.008. Epub 2012 Jan 30. Review.

PMID:
22296716
10.

Thymus-specific serine protease controls autoreactive CD4 T cell development and autoimmune diabetes in mice.

Viret C, Leung-Theung-Long S, Serre L, Lamare C, Vignali DA, Malissen B, Carrier A, Guerder S.

J Clin Invest. 2011 May;121(5):1810-21. doi: 10.1172/JCI43314. Epub 2011 Apr 18.

11.

Thymus-specific serine protease contributes to the diversification of the functional endogenous CD4 T cell receptor repertoire.

Viret C, Lamare C, Guiraud M, Fazilleau N, Bour A, Malissen B, Carrier A, Guerder S.

J Exp Med. 2011 Jan 17;208(1):3-11. doi: 10.1084/jem.20100027. Epub 2010 Dec 20.

12.

Impaired NFAT transcriptional activity in antigen-stimulated CD8 T cells linked to defective phosphorylation of NFAT transactivation domain.

Leung-Theung-Long S, Mondor I, Guiraud M, Lamare C, Nagaleekar V, Paulet PE, Rincon M, Guerder S.

J Immunol. 2009 Jun 1;182(11):6807-14. doi: 10.4049/jimmunol.0803539. Erratum in: J Immunol. 2009 Aug 1;183(3):2194. Nageleekar, Viswas [corrected to Nagaleekar, Viswas].

13.

Thymus-specific serine protease regulates positive selection of a subset of CD4+ thymocytes.

Gommeaux J, Grégoire C, Nguessan P, Richelme M, Malissen M, Guerder S, Malissen B, Carrier A.

Eur J Immunol. 2009 Apr;39(4):956-64. doi: 10.1002/eji.200839175.

14.

[Th17 cells, a novel proinflammatory effector CD4 T cell population].

Leung-Theung-Long S, Guerder S.

Med Sci (Paris). 2008 Nov;24(11):972-6. doi: 10.1051/medsci/20082411972. French.

15.

CD86 has sustained costimulatory effects on CD8 T cells.

Thomas IJ, Petrich de Marquesini LG, Ravanan R, Smith RM, Guerder S, Flavell RA, Wraith DC, Wen L, Wong FS.

J Immunol. 2007 Nov 1;179(9):5936-46.

16.
17.

Homing to nonlymphoid tissues is not necessary for effector Th1 cell differentiation.

Bajénoff M, Guerder S.

J Immunol. 2003 Dec 15;171(12):6355-62.

19.

TNF-alpha impairs peripheral tolerance towards beta-cells, and local costimulation by B7.1 enhances the effector function of diabetogenic T cells.

Skak K, Guerder S, Picarella DE, Brenden N, Flavell RA, Michelsen BK.

Eur J Immunol. 2003 May;33(5):1341-50.

20.

A novel reporter strain to follow Cre-mediated recombination in T and NK cells.

Wurtz O, Pophillat M, Schmitt-Verhulst AM, Guerder S.

Genesis. 2002 Apr;32(4):287-92.

PMID:
11948916

Supplemental Content

Loading ...
Support Center